SMTL ID : 8c13.1

Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x SYF: (2~{S},4~{R})-1-[(2~{S})-2-[3-[2-[2-[2-(acetamidomethyl)-4-(6,7-dihydro-5~{H}-pyrrolo[1,2-a]imidazol-2-yl)phenoxy]ethoxy]ethoxy]propanoylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

SYF.1: 14 residues within 4Å: Chain C: N.14, P.33, W.35, F.38, Y.45, P.46, L.48, R.54, I.56, H.57, S.58, Y.59, H.62, W.64 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:W.35, C:Y.45, C:Y.45, C:I.56, C:I.56, C:Y.59, C:W.64 Hydrogen bonds: C:N.14, C:Y.45, C:R.54, C:S.58, C:Y.59, C:Y.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schwalm, M.P. et al., Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization. Cell Chem Biol (2023)

Release Date

2022-12-28

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
J

B
K

C
L

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence